Navigation Links
Bacteria are key to 'green' plastics, drugs

Engineered bug makes key chemical precursor from grain sorghum

Trials have begun in Kansas on a "green" production method for succinate, a key ingredient of many plastics, drugs, solvents and food additives. Developed at Rice University, the technology uses a genetically modified form of the bacteria E. coli that metabolizes glucose and produces almost pure succinate.

Finding "green" methods to make key chemical intermediates like succinate is a high priority for the chemical industry. Green technologies use renewable resources like agricultural crops rather than non-renewable fossil fuels, and they produce less waste.

"Succinate is a high-priority chemical that the U.S. Department of Energy has targeted for biosynthesis," said process co-developer George Bennett, professor and chair of the department of biochemistry and cell biology at Rice. "One reason for this is succinate's broad utility -- it can be used to make everything from non-corrosive airport deicers and non-toxic solvents to plastics, drugs and food additives. Succinate's also a priority because some bacteria make it naturally, so we have a metabolic starting place for large-scale fermentation."

The centerpiece of Rice's succinate technology is a mutant form of E. coli that makes succinate as it's only metabolic byproduct. The bug contains more than a half-dozen genetic modifications. It was created over the past four years by the research groups of Bennett and collaborator Ka-Yiu San, the E.D. Butcher Professor of Bioengineering and professor of chemical and biomolecular engineering.

The technology is taking its first step from the lab to the marketplace this month with the start of industrial scale-up efforts in Kansas. These efforts resulted from an $80,000 award from the Small Business Innovation Research (SBIR) program of the U.S. Department of Agriculture. Bennett and San are working with Manhattan, Kansas-based AgRenew Inc., which just began testing how to u se farm-grown products like grain sorghum as feedstocks for the succinate-producing bacteria.

"We are very pleased for the opportunity to continue our collaboration with our colleagues from Rice and work to further the development and commercialization of the succinate technology," said Praveen Vadlani, principal research scientist for AgRenew. "We are excited about the prospects this project offers to meet a market need for the benefit of both institutions and American agriculture itself. We also appreciate the support of the U.S. Department of Agriculture for this work to create another high-value product from agriculture."

Many researchers are trying to create a succinate-producing bacterial mutant. They use biotechnology to either insert genes that boost succinate production or delete genes that interfere with it. The goal is to maximize the rate -- the speed of the conversion -- and the yield -- the amount of succinate produced per pound of glucose converted.

Bennett and San's bug -- known only by the designation SBS550MG -- contains an ingenious bit of metabolic engineering that allows it to produce succinate in two different ways. One method exists in wild strains of E. coli and has been modified with the deletion of four genes, each of which codes for a protein that interferes with or limits E. coli's ability to turn glucose into succinate. Bennett and San activated a second pathway and stimulated production by adding genes from lactococcus bacteria and sorghum.

Each genetic pathway metabolizes glucose and produces succinate via dissimilar chemical reactions. That means the two don't compete or interfere with one another. In fact, Bennett and San designed the paths to be complimentary, but even so, they were gratified to see how well the process worked once both paths were put in place.

"Our experiments in the laboratory have produced near-maximum yields, with almost all the glucose being converted into succinate," sai d San. "The implementation was actually easier than we expected because the cells did the balancing themselves."

Bennett and San said they will continue to refine the organism to produce higher yields and fewer byproducts.


'"/>

Source:Rice University


Related biology news :

1. Bacteria collection sheds light on urinary tract infections
2. Solution to Pollution: New Bacteria Eats Toxic Waste
3. The Bacterias guide to survival
4. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
5. Bacterial genome sheds light on synthesizing cancer-fighting compounds
6. Where Bacteria Get Their Genes
7. Bacteria feed on smelly breath (and feet)
8. New insight into autoimmune disease: Bacterial infections promote recognition of self-glycolipids
9. Bacteria use hosts immune response to their competitive advantage
10. Say what? Bacterial conversation stoppers
11. Researchers Discover Ancient Origins Of Tuberculosis-causing Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... -- On April 6-7, 2017, Sequencing.com will host the world,s ... at Microsoft,s headquarters in Redmond, Washington ... health and wellness apps that provide a unique, personalized ... is the first hackathon for personal genomics and the ... the genomics, tech and health industries are sending teams ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):
(Date:5/16/2017)... ... 16, 2017 , ... Zansors has secured a patent ... or EKG) acquisition and monitoring device. This Zansors’ next-generation intellectual property (IP), will ... the skin, making them significantly easier to deploy and use. , Currently, ECG ...
(Date:5/16/2017)... (UK) , ... (PRWEB) May ... ... Annual Congress of the Chinese Association of Orthopaedic Surgeons (CAOS), long-standing development ... Medical") collaborated on an interbody spine surgery workshop to help expand knowledge ...
(Date:5/15/2017)... ... 15, 2017 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that it has signed an agreement with Therachon AG, ... clinical development of TA-46, a novel protein addressing achondroplasia, which is the most ...
(Date:5/15/2017)... -- IBM (NYSE: IBM ) scientists have developed ... molecules with the potential to efficiently reveal biomarkers ... complements the IBM Research,s "lab-on-a-chip" nanoDLD technology ... which may also contain biomarkers for disease detection. ... diamond shaped micropillars 1 to pre-stretch DNA ...
Breaking Biology Technology: